New Agents and Evolving Strategies in Prostate Cancer: Focus on Castration-Sensitive Disease

In this on-demand webcast from a live webinar, Michael S. Cookson, MD, MMHC, FACS; David F. Jarrard, MD; and Atish Choudhury, MD, PhD, review the current data on managing castration-sensitive prostate cancer including data from the 2022 ASCO Genitourinary Cancers Symposium.

Atish Choudhury, MD, PhD Michael S. Cookson, MD, MMHC, FACS David F. Jarrard, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: March 14, 2022 Expired: March 13, 2023

Download these slides from a live symposium to gain more insight into the management of recurrent and metastatic CSPC.

David F. Jarrard, MD Released: February 18, 2022

Download these slides from a live symposium to learn more about the differences among available androgen-deprivation therapies for CSPC.

Michael S. Cookson, MD, MMHC, FACS Released: February 18, 2022

Download these slides from a live symposium to learn more about the new agents and evolving treatment strategies for CSPC.

Atish Choudhury, MD, PhD Released: February 18, 2022

Expert commentary by Atish Choudhury, MD, PhD, on key takeaways from a live symposium on new and evolving androgen-deprivation therapies and treatment approaches for patients with castration-sensitive prostate cancer, including data from the 2022 ASCO Genitourinary Cancers Symposium.

Atish Choudhury, MD, PhD Released: March 30, 2022